US Stock MarketDetailed Quotes

ANRO Alto Neuroscience

Watchlist
  • 12.030
  • +0.010+0.08%
Close Jun 14 16:00 ET
323.41MMarket Cap-7618P/E (TTM)

Alto Neuroscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-45.97%-10.98M
-64.01%-33.45M
-91.40%-11.52M
-7.52M
-120.19%-20.39M
-6.02M
-9.26M
Net income from continuing operations
-84.20%-13.42M
-31.02%-36.31M
-46.59%-11.22M
---7.28M
-201.62%-27.71M
---7.65M
---9.19M
Operating gains losses
2,309.09%243K
-204.34%-385K
90.19%-26K
---11K
244.86%369K
---265K
--107K
Depreciation and amortization
12.79%97K
9.06%373K
-5.15%92K
--86K
135.86%342K
--97K
--145K
Other non cash items
-3.95%170K
157.03%676K
342.50%177K
--177K
1,361.11%263K
--40K
--18K
Change In working capital
73.87%-255K
-115.24%-698K
-241.32%-1.16M
---976K
900.52%4.58M
--818K
---572K
-Change in receivables
121.62%8K
-71.93%325K
--0
---37K
190.12%1.16M
--1.02M
---1.29M
-Change in prepaid assets
-285.56%-1.79M
42.37%-34K
144.17%125K
---464K
84.64%-59K
---283K
---384K
-Change in payables and accrued expense
421.26%1.53M
-128.42%-989K
-1,742.31%-1.28M
---475K
217.23%3.48M
--78K
--1.1M
Cash from discontinued investing activities
Operating cash flow
-45.97%-10.98M
-64.01%-33.45M
-91.40%-11.52M
---7.52M
-120.19%-20.39M
---6.02M
---9.26M
Investing cash flow
Cash flow from continuing investing activities
-966.67%-224K
35.79%-470K
-467.74%-352K
-21K
-7.65%-732K
-62K
-680K
Capital expenditure reported
-966.67%-224K
35.79%-470K
-467.74%-352K
---21K
-7.65%-732K
---62K
---680K
Cash from discontinued investing activities
Investing cash flow
-966.67%-224K
35.79%-470K
-467.74%-352K
---21K
-7.65%-732K
---62K
---680K
Financing cash flow
Cash flow from continuing financing activities
438.24%134.56M
55.59%68.13M
118.81%43.13M
25M
38.19%43.79M
19.71M
31.69M
Net issuance payments of debt
----
--0
----
----
--9.83M
----
--0
Net common stock issuance
--137.58M
320.93%181K
625.00%29K
--0
514.29%43K
--4K
--7K
Net preferred stock issuance
--0
104.31%70M
348.21%45M
--25M
7.45%34.26M
--10.04M
--31.89M
Proceeds from stock option exercised by employees
--10K
----
----
--0
----
----
----
Net other financing activities
---3.03M
-501.47%-2.05M
-1,108.28%-1.9M
----
-66.34%-341K
---157K
---205K
Cash from discontinued financing activities
Financing cash flow
438.24%134.56M
55.59%68.13M
118.81%43.13M
--25M
38.19%43.79M
--19.71M
--31.69M
Net cash flow
Beginning cash position
70.75%82.55M
88.07%48.34M
47.83%51.29M
--48.34M
541.18%25.71M
--34.7M
--4.01M
Current changes in cash
606.69%123.35M
50.96%34.21M
129.33%31.26M
--17.46M
4.22%22.66M
--13.63M
--21.75M
Effect of exchange rate changes
73.68%-5K
66.67%-8K
-80.00%4K
---19K
52.00%-24K
--20K
---50K
End cash Position
213.01%205.9M
70.75%82.55M
70.75%82.55M
--65.78M
88.07%48.34M
--48.34M
--25.71M
Free cash flow
-48.54%-11.21M
-60.55%-33.92M
-95.23%-11.88M
---7.55M
-112.49%-21.13M
---6.08M
---9.94M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -45.97%-10.98M-64.01%-33.45M-91.40%-11.52M-7.52M-120.19%-20.39M-6.02M-9.26M
Net income from continuing operations -84.20%-13.42M-31.02%-36.31M-46.59%-11.22M---7.28M-201.62%-27.71M---7.65M---9.19M
Operating gains losses 2,309.09%243K-204.34%-385K90.19%-26K---11K244.86%369K---265K--107K
Depreciation and amortization 12.79%97K9.06%373K-5.15%92K--86K135.86%342K--97K--145K
Other non cash items -3.95%170K157.03%676K342.50%177K--177K1,361.11%263K--40K--18K
Change In working capital 73.87%-255K-115.24%-698K-241.32%-1.16M---976K900.52%4.58M--818K---572K
-Change in receivables 121.62%8K-71.93%325K--0---37K190.12%1.16M--1.02M---1.29M
-Change in prepaid assets -285.56%-1.79M42.37%-34K144.17%125K---464K84.64%-59K---283K---384K
-Change in payables and accrued expense 421.26%1.53M-128.42%-989K-1,742.31%-1.28M---475K217.23%3.48M--78K--1.1M
Cash from discontinued investing activities
Operating cash flow -45.97%-10.98M-64.01%-33.45M-91.40%-11.52M---7.52M-120.19%-20.39M---6.02M---9.26M
Investing cash flow
Cash flow from continuing investing activities -966.67%-224K35.79%-470K-467.74%-352K-21K-7.65%-732K-62K-680K
Capital expenditure reported -966.67%-224K35.79%-470K-467.74%-352K---21K-7.65%-732K---62K---680K
Cash from discontinued investing activities
Investing cash flow -966.67%-224K35.79%-470K-467.74%-352K---21K-7.65%-732K---62K---680K
Financing cash flow
Cash flow from continuing financing activities 438.24%134.56M55.59%68.13M118.81%43.13M25M38.19%43.79M19.71M31.69M
Net issuance payments of debt ------0----------9.83M------0
Net common stock issuance --137.58M320.93%181K625.00%29K--0514.29%43K--4K--7K
Net preferred stock issuance --0104.31%70M348.21%45M--25M7.45%34.26M--10.04M--31.89M
Proceeds from stock option exercised by employees --10K----------0------------
Net other financing activities ---3.03M-501.47%-2.05M-1,108.28%-1.9M-----66.34%-341K---157K---205K
Cash from discontinued financing activities
Financing cash flow 438.24%134.56M55.59%68.13M118.81%43.13M--25M38.19%43.79M--19.71M--31.69M
Net cash flow
Beginning cash position 70.75%82.55M88.07%48.34M47.83%51.29M--48.34M541.18%25.71M--34.7M--4.01M
Current changes in cash 606.69%123.35M50.96%34.21M129.33%31.26M--17.46M4.22%22.66M--13.63M--21.75M
Effect of exchange rate changes 73.68%-5K66.67%-8K-80.00%4K---19K52.00%-24K--20K---50K
End cash Position 213.01%205.9M70.75%82.55M70.75%82.55M--65.78M88.07%48.34M--48.34M--25.71M
Free cash flow -48.54%-11.21M-60.55%-33.92M-95.23%-11.88M---7.55M-112.49%-21.13M---6.08M---9.94M
Currency Unit USDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion----------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Recent IPOs
Recent IPOs
Intraday-2.03%